AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study

[31] Souza SC(2003)Role of adiponectin in matching of fetal and placental weight in mothers with type 1 diabetes Diabetes 52 1355-1363

[32] Villena JA(2003)Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation Diabetes 52 667-674

[33] Viollet B(2006)Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes Curr Med Res Opin 22 1921-1926

[34] Andreelli F(2005)Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy Eur J Pharmacol 518 90-95

[35] Kahn A(2010)Effect of gliclazide modified release of adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus Diabetologia 53 768-778

[36] Vaulont S(2008)Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase J Clin Pharmacol 48 696-707

[37] Sul HS(2006)Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase J Lipid Res 47 2444-2450

[38] Habinowski SA(2002)Population exposure-response modeling of metformin in patients with type 2 diabetes mellitus Diabetes 51 30-36

[39] Witters LA(1998)The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment Diabetes Care 21 1301-1305

[40] Salt IP(2005)Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects Diab Obes Metab 7 381-389

[31] Souza SC(2003)Role of adiponectin in matching of fetal and placental weight in mothers with type 1 diabetes Diabetes 52 1355-1363

[32] Villena JA(2003)Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation Diabetes 52 667-674

[33] Viollet B(2006)Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes Curr Med Res Opin 22 1921-1926

[34] Andreelli F(2005)Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy Eur J Pharmacol 518 90-95

[35] Kahn A(2010)Effect of gliclazide modified release of adiponectin, interleukin-6, and tumor necrosis factor-alpha plasma levels in individuals with type 2 diabetes mellitus Diabetologia 53 768-778

[36] Vaulont S(2008)Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase J Clin Pharmacol 48 696-707

[37] Sul HS(2006)Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase J Lipid Res 47 2444-2450

[38] Habinowski SA(2002)Population exposure-response modeling of metformin in patients with type 2 diabetes mellitus Diabetes 51 30-36

[39] Witters LA(1998)The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment Diabetes Care 21 1301-1305

[40] Salt IP(2005)Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects Diab Obes Metab 7 381-389